GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » Price-to-Owner-Earnings

GemPharmatech Co (SHSE:688046) Price-to-Owner-Earnings : (As of Jun. 01, 2025)


View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co Price-to-Owner-Earnings?

As of today (2025-06-01), GemPharmatech Co's share price is ¥12.36. GemPharmatech Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for GemPharmatech Co's Price-to-Owner-Earnings or its related term are showing as below:


SHSE:688046's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 29.07
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-06-01), GemPharmatech Co's share price is ¥12.36. GemPharmatech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.27. Therefore, GemPharmatech Co's PE Ratio (TTM) for today is 45.78.

As of today (2025-06-01), GemPharmatech Co's share price is ¥12.36. GemPharmatech Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥0.32. Therefore, GemPharmatech Co's PE Ratio without NRI for today is 38.50.

During the past 7 years, GemPharmatech Co's highest PE Ratio without NRI was 73.81. The lowest was 20.92. And the median was 42.08.


GemPharmatech Co Price-to-Owner-Earnings Historical Data

The historical data trend for GemPharmatech Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co Price-to-Owner-Earnings Chart

GemPharmatech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

GemPharmatech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of GemPharmatech Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, GemPharmatech Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GemPharmatech Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GemPharmatech Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where GemPharmatech Co's Price-to-Owner-Earnings falls into.


;
;

GemPharmatech Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

GemPharmatech Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=12.36/-0.04
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GemPharmatech Co  (SHSE:688046) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


GemPharmatech Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


GemPharmatech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032
GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co Headlines

No Headlines